Aug 10, 2023 / 12:30PM GMT
Operator
Good morning and welcome to the Q2 2023 Financial Results Conference Call for HLS Therapeutics. On this morning's call, we have Craig Millian, Chief Executive Officer and Tim Hendrickson, Chief Financial Officer. (Operator Instructions) Earlier this morning HLS issued a news release announcing its financial results for the 3 and 6 months ended June 30th, 2023. This news release along with the company's MD&A and financial statements are available on HLS's website and on SEDAR. Please note that the slides accompanying today's call can be viewed via the webcast, a link of which is available on the company's earnings press release and on its website on the events page.
Certain matters discussed in today's conference call or answers that may be given to questions could constitute forward looking statements. Actual results could differ materially from those anticipated. Risk factors that could affect results are detailed in the company's annual information form, which have been filed on SEDAR at www.sedar.com. During the conference call,
Q2 2023 HLS Therapeutics Inc Earnings Call Transcript
Aug 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers